91Ó°ÊÓ

Ketamine and Social Anxiety Disorder (Example 7) According to the National Institute of Mental Health, Social Anxiety Disorder (SAD) is a mental health disorder that affects up to \(7 \%\) of the population of the United States. Because many SAD patients experience inadequate symptom relief with available treatments, researchers in this study investigated the use of ketamine to treat SAD patients (Taylor et al. 2018 ). Read the following excerpts from the study abstract and evaluate the study using the given questions. Methods: We conducted a double-blind, randomized, placebo-controlled crossover trial in 18 adults with Social Anxiety Disorder and compared the effects between intravenous ketamine and placebo on social phobia symptoms. Ketamine and placebo infusions were administered in a random order with a 28 -day washout period between infusions. Ratings of anxiety were assessed 3 -hours post-infusion and followed for 14 days. Outcomes were blinded ratings on the Liebowitz Social Anxiety Scale (LSAS) and self-reported anxiety on a visual analog scale (VAS-Anxiety). Results: We found ketamine resulted in a significantly greater reduction in anxiety relative to placebo on the LSAS \((p=0.01)\) but not the VAS-Anxiety \((p=0.95)\). Participants were significantly more likely to exhibit a treatment response after ketamine infusion relative to placebo in the first 2 weeks following infusion measured on the LSAS \((33.33 \%\) response ketamine vs \(0 \%\) response placebo, \(p=0.025\) ) and VAS \((88.89 \%\) response ketamine vs \(52.94 \%\) response placebo, \(p=0.034)\). Conclusion: This trial provides initial evidence that ketamine may be effective in reducing anxiety.

Step by step solution

01

Understand the Research Methods

Analyze the research methodology used. The researchers conducted a double-blind, randomized, placebo-controlled crossover trial involving 18 adults with Social Anxiety Disorder (SAD). Participants were subjected to ketamine and placebo infusions in a random order, with a 28-day washout period in between. Anxiety levels were assessed 3-hours post-infusion and the participants were followed for 14 days. Two primary tools for assessing outcomes were the Liebowitz Social Anxiety Scale (LSAS) and the Visual Analog Scale (VAS).

02

Interpret the Results

With the research methods understood, let's now interpret the results obtained from this study. The results showed that ketamine resulted in a significantly greater reduction in anxiety relative to placebo on the LSAS \((p=0.01)\) but not on the VAS-Anxiety \((p=0.95)\). Participants were significantly more likely to respond to ketamine treatment compared to the placebo in the first 2 weeks post-infusion according to both LSAS (\(33.33 \%\) for ketamine vs \(0 \%\) for placebo, \(p=0.025\)) and VAS ( \(88.89 \%\) for ketamine vs \(52.94 \%\) for placebo, \(p=0.034\)). The \(p\) values denote levels of statistical significance; lower values indicate more significant results.

03

Formulate a Conclusion

Based on the results of the study, one can infer that ketamine may be effective in reducing symptoms of social anxiety. This inference stems from the significantly greater reduction of anxiety observed on the LSAS, and the fact that, post-infusion, participants were significantly more likely to respond to ketamine treatment relative to the placebo. However, it's noteworthy that ketamine did not yield significant effects on the VAS-Anxiety scale.

04

Consider the Limitations

It's also crucial to acknowledge the limitations of this study, including the small sample size (18 adults), which may limit the generalizability of the results. Also, this was a controlled experiment carried out in a specific setting, and real-world results may vary.

Unlock Step-by-Step Solutions & Ace Your Exams!

• Full Textbook Solutions

  Get detailed explanations and key concepts

• Unlimited Al creation

  Al flashcards, explanations, exams and more...

• Ads-free access

  To over 500 millions flashcards

• Money-back guarantee

  We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Ketamine Treatment

Ketamine, known primarily as an anesthetic, is gaining attention for its potential in treating mental health disorders, including Social Anxiety Disorder (SAD).

In recent studies, such as the one conducted by Taylor et al., ketamine is evaluated for its efficacy in providing relief from the symptoms of SAD, which affects a significant portion of the population.

• In this study, ketamine was administered intravenously to adults diagnosed with SAD.
• Administered alongside a placebo in a controlled environment, researchers aimed to observe any reductions in anxiety levels post-treatment.

Results from the study indicated a more significant reduction in symptoms when ketamine was used compared to the placebo, suggesting its potential as an alternative treatment. However, while promising, these results require further exploration due to the limited sample size and controlled conditions.

Randomized Controlled Trial

The strength of research, especially in medical fields, often relies on the validity and reliability of its methodology. A randomized controlled trial (RCT) is considered the gold standard due to its ability to minimize bias.

In the context of the ketamine study, the researchers designed a double-blind, placebo-controlled crossover trial. This involved:

• Assigning participants randomly to receive either ketamine or a placebo initially.
• Ensuring both participants and administrators were "blind" or unaware of which treatment was being received, reducing subjective influence.
• After a set washout period, switching the treatments for each participant.

Such a rigorous design provides a credible basis for comparing the efficacy of ketamine against the placebo, strengthening the claim that ketamine may benefit SAD patients.

Liebowitz Social Anxiety Scale

The Liebowitz Social Anxiety Scale (LSAS) is a recognized tool used to assess the severity of social phobia symptoms. In the ketamine study, the LSAS served as one of the primary measures for evaluating treatment outcomes.

The LSAS works by measuring both the fear and avoidance aspects of social interactions through a series of questions.

• Participants rate their experience in different social situations.
• Scores indicate the degree to which social anxiety affects their lives.

This scale's integration into the study allowed researchers to quantitatively evaluate changes in anxiety levels post-ketamine infusion, demonstrating a statistically significant reduction in anxiety levels for participants receiving ketamine compared to those given a placebo.

Statistical Significance

Understanding whether a result is statistically significant is crucial in research, as it determines whether findings can confidently be attributed to an intervention – like ketamine – rather than by chance.

In the ketamine study, the term "statistical significance" indicates that the reductions in anxiety levels, as measured by the LSAS post-ketamine infusion, were not likely to have happened by random chance.

• Typically, a p-value of less than 0.05 is considered statistically significant.
• In the study, the p-value for ketamine's effects on LSAS was 0.01, supporting the hypothesis that ketamine reduced anxiety symptoms significantly compared to placebo.

However, the VAS-Anxiety scale did not show significant results (p=0.95), highlighting the importance of using multiple evaluative tools to comprehensively assess the efficacy of treatments like ketamine.